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1 PREOPERATIVE IMAGING OF HILAR
CHOLANGIOCARCINOMA
Hadian A3, Romaneehse B1, Lohse A2, Thelen M1, Otto G3,
(1) Klinik for Radiologie, Mainz; (2) I. Medizinische Klinik, Mainz;
(3) Transplantationschirurgie/Chirurgie von Leber, Gallenwegen
und Pankreas, Mainz, Germany
INTRODUCTION AND AIM: Therapeutic decisions in hilar
cholangiocarcinoma depend mainly on the longitudinal extention of
tumor growth along the bile ducts and on the recognition of distant
metastases. Preoperative imaging is increasingly used to define
the surgical strategy preoperatively. At the same time, accurate
diagnostic evaluation must not delay treatment, and should be cost-
effective. PATIENTS AND METHODS: Between 9/97 and 12/02,
82 patients with hilar cholangiocarcinoma were treated at our insti-
tution. For the retrospective analysis reported herein 55 of the initial
59 ERCP images, 39 of the initial 40 MRCs and 32 of the initial
38 PTCs were available. ERC and MRC had been performed at
the referring institutions by various investigators in 48 and 17 cases,
respectively. RESULTS: The mean scores (+ standard deviation) of
visualization for ERC, MRC, and PTC differ considerably. The
results for ERC were significantly worse than those of MRC
(p50.001) PTC (p50.001), but MRC was also inferior to PTC
(p=0.019). ERC scored 1.23 (+0.94) for the right biliary system
and 0.97 (+0.77) for the left lobe, respectively. MRC resulted in a
appropriate visualization in about 90%, right and left system inclu-
ded. In PTC the visualization of the bile ducts was always perfect.
CONCLUSION: ERC may help to recognize a hilar stricture but
not its precise localization and intrahepatic extension. Visualization
reached by MRC and PTC is significantly better than by ERC. PTC
in particular was found to be the most reliable tool to classify hilar
cholangiocarcinomas before surgery.
2 CHOLANGIOCARCINOMA AS AN EXTENDED
INDICATION IN LIVING-DONOR LIVER
TRANSPLANTATION
Jonas S, Mittler J, Pascher A, Theruvath T, Thelen A, Klupp J,
Langrehr J, Neuhaus P, General, Visceral and Transplantation
Surgery, Charite´ Campus Virchow-Klinikum, Berlin, Germany
INTRODUCTION AND AIM: The advantages of living donor liver
transplantation are an individually available graft and a tremendously
reduced waiting-time until transplantation. One consequence is
that many centers have extended the pretransplant selection criteria
especially for potential recipients suffering from hepatocellular
carcinoma. In contrast, reports on living donor liver transplan-
tation for cholangiocarcinoma are restricted to few case reports.
PATIENTS AND METHODS: We have analyzed our experience
with 7 patients suffering from cholangiocarcinoma (Klatskin tumors,
n=5; intrahepatic cholangiocarcinoma, n=2). RESULTS: During
a median follow-up of 20 months (range 2–46 months), all patients
are alive except for one post-transplant death. Four patients suffering
from Klatskin tumors are alive without recurrence; both patients
suffering from intrahepatic cholangiocarcinoma are alive with bone
and peritoneal metastases. CONCLUSION: Living donor liver
transplantation may be beneficial in selected patients suffering from
Klatskin tumors while caution should prevail when considering
intrahepatic cholangiocarcinoma.
3 KLATSKIN TUMORS – TREATMENT MODALITIES
IN A SINGLE-CENTER EXPERIENCE
Skwarek A, Zieniewicz K, Nyckowski P, Wroblewski T, Michalowicz
B, Patkowski W, Najnigier B, Remiszewski P, Pawlak J, Krawczyk M,
Department of General, Transplant and Liver Surgery, Medical
University, Warsaw, Poland
INTRODUCTION AND AIM: To evaluate the methods of treat-
ment of patients with Klatskin tumors in one center. PATIENTS
AND METHODS: The study group comprised 164 patients (88
female, 76 male, mean age 59 years) with Klatskin tumor, treated
in the period 1994–2003. RESULTS: The main clinical symptoms
were: jaundice (100%), pruritus (84%), abdominal pain (52%) and
cholangitis (24%). 50.6% patients underwent surgical treatment
with curative intention: resections of the extrahepatic bile ducts
28.9%, bile ducts with adjacent liver tissue: left hepatectomy 28.9%,
left hepatectomy+segment I 8.4% and extended right hepatec-
tomy+segment IV 33.8%. In other cases (49.4%) palliative proce-
dures were performed: intrahepatic segment III/V cholangiojejunal
anastomosis in 36 patients, endoscopic stenting in 28 patients
and percutaneous transhepatic drainage in 17 patients. In a group
of patients treated surgically with curative intention perioperative
mortality was 3.8% and 1-year overall survival (OS) rate was 26%.
In the group of patients treated palliatively 30-day mortality was
7.3% and 1-year OS rate was 10.9%. CONCLUSION: The optimal
treatment option for Klatskin tumor patients remains surgical
resection, however associated with low mortality, is rarely possible.
For palliative treatment in patients in poor general status the
recommended method is endoscopic stenting or percutaneous
transhepatic drainage.
4 GASTROJEJUNOSTOMY WITH DUODENAL
PARTITION FOR UNRESECTABLE
PERIAMPULLARY CANCER
Shin JH, Han WK, Surgery, Kangbuk Samsung Hospital,
Sungkyunkwan University School of Medicine, South Korea
INTRODUCTION AND AIM: The most appropriate palliative
treatment to relieve symptoms caused by extrahepatic biliary
obstruction appears to be a surgically constructed double bypass.
However, gastrojejunostomy may be a disease rather than an oper-
ation because the ingested food would take the duodenal route and
re-enter the stomach through the gastrojejunostomy. Therefore,
there has been a renewed interest in the role of the duodenal
partition for preventing this circulus vomiting. PATIENTS AND
METHODS: A total of 97 patients were treated with palliative
loop gastrojejunostomy due to unresectable periampullary cancer
at Kangbuk Samsung Hospital between March 2001 and December
2003. Of the 56 patients in this group who underwent prophylactic
gastrojejunostomy, 25 patients had both gastojejunostomy and
duodenal partition (Group I) and 31 had gastrojejunostomy alone
(Group II). RESULTS: The postoperative in-hospital mortality rate
was 0% and the morbidity rate was 5.4%. However, the morbidity
rate associated with duodenal partition was 0%. Circulus vomiting
was absent in patients who had a duodenal partition, although
statistical analysis did not show this to be significant. The reason
for the statistical insignificance of the result may be the relatively
small sample size. CONCLUSION: Due to the ease and safety of
the technique, the duodenal partition added to the loop gastro-
jejunostomy decreased circulus vomiting without prolonging the
operative time or increasing the complication rates. This finding
suggests that the duodenal partition should be liberally applied in
prophylactic gastric bypass procedures.
5 INTRAOPERATIVE BILIARY SELF-EXPANDABLE
METALLIC STENT PLACEMENT IN UNRESECTABLE
HILAR CHOLANGIOCARCIONOMAS
Karaliotas C2, Sgourakis G1, Goumas C1, Christofidis T1,
Papaioannou N3, Karaliotas C3, (1) 2nd Department of Surgery;
(2) Gastroenterology; (3) Surgical Oncology Unit, Red Cross
Hospital, Athens, Greece
INTRODUCTION AND AIM: We introduce the method of
introperative biliary metallic stent placement in unresectable
cholangiocarcionomas, where percutaneous and endoscopic pro-
cedures have failed. PATIENTS AND METHODS: From March
2001 to October 2004, 13 patients with unresectable hilar cholan-
giocarcinomas underwent intraoperative placement of metallic bili-
ary stents. An unyielding effort (endoscopically or percutaneously)
had been done preoperatively. After choledochotomy, a metallic
self-expandable stent is introduced after forceful tumor pierce with
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a bougie. A T-tube is inserted in the CBD and a completion
cholangiogram is performed in order to investigate stent position
and drained hepatic segments. In case of undrained liver lobe
or sustained jaundice, an effort for PTBD was done on the second
postoperative day. A second cholangiogram was done on the 15th
postoperative day. 50 Gy external beam radiotherapy was adminis-
tered postoperatively. RESULTS: Successful introperative metallic
biliary stent placement was feasible in 12 of 13 patients. In 9 of 12
patients the stent was placed in the left biliary tree. PTBD was
done in 2 postoperatively. No bile leaks were observed. Cholangitis
and moderate degree of hemobilia was dealt with successfully in
two patients. 30-day mortality was 7.6% (1/13). Procedural mortality
was nil. Relief of jaundice in 91.6% (11/12). Recurrent jaundice
in 16.6% (2/12). Median survival was 410 days. Mean stent patency
was 9.8 months. Mean length of hospital stay was 10.4 days. Average
monthly Karnofsky score was 72.1. CONCLUSION: Introperative
placement of self-expandable metallic biliary stents for unresectable
hilar cholangiocarcinomas is a safe and effective method.
6 INDICATIONS AND OUTCOME OF ENDOSCOPIC
PAPILLECTOMY OF THE MAJOR AND MINOR
PAPILLA – A PROSPECTIVE 5-YEAR STUDY
Will U1, Meyer F3, Gottschalk P2, Bosseckert H2, (1) Department
of Internal Medicine III, Municipal Hospital Gera, Gera, Germany;
(2) Department of Internal Medicine I, University Hospital Jena,
Jena, Germany; (3) University Hospital Magdeburg, Department
of Surgery, Magdeburg, Germany
INTRODUCTION AND AIM: To study indication and outcome
of papillectomy in suspicious tumor lesions of the papilla of Vater.
PATIENTS AND METHODS: 22 males and 17 females (21–88
years) underwent endoscopic papillectomy because of a polypoid
tumor at the papilla revealed by EUS over 5 years. Follow-up EUS
including histologic investigation were performed within 28 days.
RESULTS: Group (Gr.) 1 (n=21): Adenoma (n=18), uT1 Ca of
high risk patients (n=3) with R0 resection (n=17) vs R1 (n=4; all
reapproached using argon beamer). On the 28th post-interventional
day, all subjects were free of tumor (recurrent tumor growth, n=3
after 6, 18 and 26 months; range [n=14], 3–60 months). Gr.2
(n=8): Contradiction between EUS (infiltrating tumor growth) and
histologic finding (adenoma or unspecific inflammation); histological
findings: Adenomyomatosis of the papilla (n=5), infiltrating Ca
of the papilla or peripapillary region (n=3). Gr.3 (n=4): Neuro-
endocrine tumors of the major (n=2) or minor papilla (n=2):
2 benign, 1 Ca and 1 carcinoid tumor. Gr.4 (n=6): Not introducible
catheter through the minor papilla in suspected pancreas divisum
(n=2) or through the major papilla (n=1) after previous Billroth II
or because of Ca of the papilla (n=3): Catheter insertion was
achieved after papillectomy (n=3) or partial tumor resection (n=3).
CONCLUSION: Papillectomy is feasible for diagnostic as well as
therapeutic requirements in (i) polypoid tumors of the papilla, (ii)
infiltrating tumor growth revealed by EUS and negative histologic
investigation (optional:+deep biopsy), and (iii) tumor lesion,
through which catheter cannot be placed to get access to the
pancreatobiliary system.
7 GALLBLADDER CARCINOMA: IS AN
AGGRESSIVE SURGICAL APPROACH JUSTIFIED?
Del Gaudio M1, Grazi GL1, Ercolani G1, Cucchetti A1, Principe A2,
(1) Liver and Multiorgan Transplantation; (2) Liver Surgery,
University of Bologna, Bologna, Italy
INTRODUCTION AND AIM: The surgical treatment of gall-
bladder cancer (GBC) has improved significantly in recent years.
The aim of this study is to evaluate retrospectively the long-term
results of surgical treatment of GBC according to the TNM stage
AJCC-2002. PATIENTS AND METHODS: We considered 118
patients with GBC treated between 1982 and 2003. 74 (63%) were
female and 44 (37%) males; overall age was 63 years (range 38–91).
Incidental tumor was found during cholecystectomy (CT) in 25
(21%) patients. RESULTS: Among 118 patients with GBC, 35
(36%) were treated radically: 3 pTNM IA (3 CT), 10 IB (3CT,
3 CT+hepatic resection (HR), 4 HR), 3 IIA (3 HR), 6 IIB (3
CT+HR+extrahepatic bile duct resection (BDR), 3 HR), 11 III
(4 CT+HR, 5 extensive HR (eHR), 1 HR+right colectomy+
BDR+total gastrectomy, 1 hepato-pancreatoduodenectomy+CT),
2 IV (2 eHR). 1-, 3-, 5-year survival was 67%, 46%, 34% for pTNM
IA-IB; 63%,12%, 12% for IIA-IIB; 50%, 30%, 30% for III-IV
(p=ns); in particular, 1-, 5- year survival was 100%, 100% for T1a;
50%, 50% for T1b; 70%, 35% for T2; 50%, 12% for T3; 54%, 32%
for T4 (p=ns); 1-, 3-, 5-year survival for patients without lymph
node involvement was 58%, 44%, 37% and 60%, 15%, 15% for
patients with lymph node metastases (p=ns). CONCLUSION: CT
seems to be sufficient in T1a patients but inadequate in T1b (stage
IA), in which a more aggressive surgical treatment is indicated. In
stage IIB, III and IV, the presence of lymph node metastasis is not
a contraindication to aggressive surgery.
8 ENDOSCOPIC AMPULLECTOMY: A NEW
APPROACH FOR TREATMENT OF SMALLS TUMORS
OF VATER’S PAPILLA
Karsenty L, Bloch P, Endoscopy and Visceral Surgery,
American Hospital of Paris, Neuilly Sur Seine, France
INTRODUCTION AND AIM: Surgery is not an easy technique in
treatment of small benign or neoplasic T1 tumors of Vater’s papilla.
A lot of side effects are described with this technique, particularly
anastomotic fistula and sometimes death. Duodenopancreatectomy
is not recommended for small tumors. Endoscopic resection may
be proposed as an alternative to surgery. The aim of this study is
to evaluate this new approach. PATIENTS AND METHODS:
Between January 2003 and September 2004, 32 ampullomas were
diagnosed by endoscopy or endoscopic ultrasound. 9 of these were
benign or neoplasic T1 (European classification) tumors. Tumoral
staging was performed (CT scan, endoscopic ultrasound and mini-
probe ultrasound). Evaluation of benefits and risks was done. In
these 9 cases we decided to perform endoscopic resection. All of
them were performed under complete anesthesia with a video-
duodenoscope and a diathermic snare. Pancreatic stent was put
in all cases. Finally, pathologic analysis was made after resection.
RESULTS: Complete resection was performed in all cases. 1 was
classified T2 after pathologic analysis and duodenopancreatectomy
was performed. 1 pancreatitis was described but without clinical
symptoms (increase of pancreatic enzymes), and treated only by
fasting during 3 days. No bleeding, retroperitoneal perforation, or
infectious complication were observed. Long-term evaluation was
not easy because of the shortness of the study, but no pancreatic
duct stenosis or neoplasic relapse has been seen. CONCLUSION:
Endoscopic ampullectomy is a safe procedure. Surgery is recom-
mended for bigger tumors. Further evaluation is necessary to confirm
these preliminary results.
9 VALIDATION OF A NEW CLINICAL-BIOCHEMICAL-
RADIOLOGICAL STAGING SYSTEM FOR GALL
BLADDER CANCER
Shukla PJ, Shrikhande SV, Pandey D, Goliwale F, GI Surgical
Oncology, Tata Memorial Hospital, Mumbai, India
INTRODUCTION AND AIM: Gallbladder cancer is one of
the commonest GI cancers in Northern India. At the 6th World
Congress of the IHPBA we had proposed a new staging system
based on clinical-biochemical-radiological parameters. Aim: To
validate the new clinico-biochemical-radiological staging system
in order to pre-operatively predict the resectability and help in
formulating treatment options. PATIENTS AND METHODS:
Approximately 160 new patients with gallbladder cancer are received
annually at our centre. These include patients with resectable
disease, incidentally diagnosed (post-cholecystectomy) disease or
advanced disease. In addition to the CT scan features, the presence/
absence of jaundice and the serum CA-19-9 tumour marker levels
are included in an objective manner to predict advanced disease
and inoperability. RESULTS: In the period January 2003 to October
2004, 27 patients with gallbladder cancer were subject to surgical
exploration. The successful resectability rate was only 33% (9/27).
This group does not include those patients who were taken up for
revision surgery following prior simple cholecystectomy for malig-
nancy. The reasons for unresectability included: extensive nodal
disease, porta hepatis invasion, peritoneal nodules and non-
contiguous liver metastases. The new staging system (which
includes: presence of jaundice, elevated CA-19-9 and CT scan
features suggesting extension of disease medially towards the porta
hepatis/nodal disease) correlated very favorably with predicting
unresectability. 90% of the patients with unresectable disease had
at least one or more adverse factors on the staging system.
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CONCLUSION: By pre-operatively staging the disease in these
patients with the proposed new system, it is possible for us to
streamline treatment strategies for these patients with objectives of
predicting resectability and prognostication. We believe that this
system complements the existing TNM and Nevin staging systems
and provides a practical clinical based system.
10 HILAR CHOLANGIOCARCINOMA (KLATSKIN
TUMOR): CURRENT MANAGEMENT
Tsalis K1, Vasiliadis K1, Vergos O1, Kalpakidis V2, Christoforidis E1,
Tsachalis T1, Betsis D1, (1) 4th Surgical Department, Aristotle
University of Thessaloniki; (2) Department of Radiology,
“G. Papanikolaou” General Hospital of Thessaloniki,
Thessaloniki, Greece
INTRODUCTION AND AIM: Hilar cholangiocarcinoma is
generally considered to be one of the most difficult malignant tumors
with poor prognosis. Long-term survival can be achieved only after
surgical resection, when possible. The aim of this study is to present
our experience of the management of 33 patients with hilar cholan-
giocarcinoma. PATIENTS AND METHODS: From January 1993
to August 2004, 33 patients (25 men, 8 women) with Klatskin
tumor referred to our department. The diagnosis was based on the
clinical evaluation, laboratory tests, tumor marker levels and careful
evaluation of the extent of the tumor (US, CT, MRI, MRCP, ERCP,
PTC). 14 patients had resection of all gross disease and 10 of them
had negative histologic margins. Five patients underwent left hepa-
tectomy combined with caudate lobe resection. The 30-day mortality
rate after tumor resection was 7.1%. Fourteen patients were treated
with palliative surgical procedures and 5 patients underwent non-
surgical treatment. RESULTS: The resectability rate was 42.4%.
Overall survival rate for patients with tumor resection ranged from
6 months to 7.5 years (mean 24.16 months) and for patients with
palliative treatment from 1 to 17 months (mean 8.67 months). The
mean survival rate in patients with a negative histologic margin was
30.6 months while in those with a positive margin it was 11 months.
CONCLUSION: An aggressive surgical approach is warranted in
patients with hilar cholangiocarcinoma because resection offers
the only hope for long-term survival. Our findings emphasize the
importance of achieving tumor-free margins.
11 ENDOSCOPIC BILIARY STENTING FOR
CHOLANGIOCARCINOMA: A 5-YEAR EXPERIENCE
Barlow A, Pattenden CJ, Garcea G, Neal C, Dennison A, Berry D,
Hepatobiliary Surgery, Leicester General Hospital, Leicester, UK
INTRODUCTION AND AIM: Endoscopic biliary stenting, both
in the pre-operative optimisation of surgical candidates and as a
palliative procedure, is an integral part of the management of patients
with cholangiocarcinoma. The aim of this study was to determine
the incidence of cholangitis in these patients. PATIENTS AND
METHODS: Patients were identified from the multidisciplinary
team database. Data including demographic details, procedures,
outcome and microbiological cultures were collected on a com-
puterised database. RESULTS: 116 patients (55 males, 61 females)
with a diagnosis of cholangiocarcinoma were seen in our unit
between 1999 and 2004. Of these, 104 (90%) underwent endoscopic
retrograde cholangiopancreatography (ERCP), with a total of 198
performed. 92 (88%) of these patients underwent plastic biliary
stenting. Curative surgical resection was later attempted in 43 (37%)
of the total patient group. The original stent was changed in 30 (35%)
patients, the median number of stent placements was 1 (range 1–6).
Overall there were 0.21 stent changes per month of survival. Only
24 (26%) patients with stents in situ developed clinical features
of cholangitis. CONCLUSION: The majority of patients with
cholangiocarcinoma require biliary stenting, often repeatedly.
Despite this, 530% display clinical signs of cholangitis following
biliary stent placement.
12 THE EFFECT OF THE PREOPERATIVE ERCP ON
THE INFECTIOUS COMPLICATIONS OF PATIENTS
OPERATED ON FOR HILAR CHOLANGIOCARCINOMA
Zsirka-Klein A, Lukovich P, Kupcsulik P, 1st Department
of Surgery, Semmelweis University, Budapest, Hungary
INTRODUCTION AND AIM: A rare cause of mechanical
jaundice is hilar cholangiocarcinoma. The average size of the
tumour is 3–4 cm, so it is difficult to find by way of imaging exam-
inations. For this reason very often an ERCP examination is made
in order to establish the diagnosis. A preoperative bile duct stent
is implanted to solve the jaundice. PATIENTS AND METHODS:
In the last 12 years 51 patients were resected due to Klatskin tumour
in our department. In the case of 33 patients the examination
included an ERCP examination (ERCP group), of which in 10 cases
a stent was implanted as well. In 18 cases no ERCP examination
was made (NERCP group). In the ERCP group a bacteriological
examination of the bile of the proximal ducts was made in 21 cases, as
long as in the NERCP group this happened in 11 cases. In both
groups we analyzed the result of the bacteriological investigation, the
antibiotic resistance of the organisms and the rate of postoperative
complications. RESULTS: The bacteriological investigation of
the bile in the ERCP group showed a multi-bacterial infection with
multi-resistant organisms. The most frequent pathogens were:
Pseudomonas spp., Acinetobacter spp., Streptococcus spp. and Entero-
coccus spp. In this group wound infection and pneumonia were
more frequent and hospitalization was also longer. As long as in
the NERCP group there was no postoperative death, 4 patients
in the ERCP group died of sepsis in the postoperative period.
CONCLUSION: ERCP examination of patients with Klatskin
tumours significantly increases the infection risk of the proximal
bile ducts with multi-resistant pathogens, and through this, the rate
of postoperative septical complications. If the ultrasound exami-
nation to be first opted for in case of a mechanic jaundice shows a
choledocus of normal diameter, Klatskin tumour should be sus-
pected. In such cases MR cholangiography and eventually PTC are
recommended. Taking the results of the bacteriological examinations
into consideration, as opposed to the antibiotics used in bile surgery,
the antibiotic prophylaxis chosen should be such as can be thera-
peutically applied later in case of a persistent infection.
13 REVERSE WILL ROGERS PHENOMENON IN
HILAR CHOLANGIOCARCINOMA
Moebius C2, Wiedmann M1, Caca K1, Uhlmann D2, Hauss J2,
Witzigmann H2, (1) Department of Internal Medicine II,
University of Leipzig; (2) 2nd Department of Surgery,
University of Leipzig, Leipzig, Germany
INTRODUCTION AND AIM: Possible causes underlying the
substantial differences in hilar cholangiocarcinoma survival rates
observed between Japan and the west may be due to insufficient
lymph node dissection in the western world. Therefore, we evaluated
disease-free survival rates in our resected patients in relation to
extent of lymph node dissection in a retrospective study. PATIENTS
AND METHODS: This study involved 60 patients who underwent
resection for histologically proven hilar cholangiocarcinoma in a
single centre between 1994 and 2003. Patients were divided into
2 different groups. The first group (n=26) included patients with
a maximum of 2 lymph nodes dissected and the second group
(n=20) included patients with at least 3 lymph nodes dissected.
RESULTS: 14 patients were excluded from the study because of
incomplete tumor resection or because N status was not available.
There was no difference between sex, age, operating procedure and
morbidity in the two groups. There were 3 patients with pN+ status
in group 1 and 12 patients with pN+ status in group 2. The median
disease-free survival in group 1 was 22.8 months and in group 2 the
median disease-free survival was 33.07 months. CONCLUSION:
It seems likely that the reverse of the Will Rogers phenomenon – that
is, less careful staging of patients leading to a lowering of the survival
of all stages – accounts for the so far unexplained variations between
Japan and the Western world in our study population.
14 INTRAHEPATIC HEPATICO-JEJUNOSTOMY IN
THE TREATMENT OF PATIENTS WITH UNRESECTABLE
KLATSKIN TUMORS
Nyckowski P, Skwarek A, Zieniewicz K, Patkowski W, Najnigier B,
Michalowicz B, Wroblewski T, Smoter P, Dudek K, Krawczyk M,
Department of General, Transplant and Liver Surgery, Medical
University, Warsaw, Poland
INTRODUCTION AND AIM: The authors present the results of
the treatment of patients with unresectable Klatskin tumor with
the use of intrahepatic hepatico-jejunostomy in segment III or V.
PATIENTS AND METHODS: Retrospectively analyzed records of
36 patients (16 male, 20 female; mean age:49 years) comprised
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37.5% of all the patients treated from 1994 to 2003 for Klatskin
tumor. The main clinical symptoms were: jaundice (100%), pruritus
(85%) and cholangitis (24%). In 9 cases before the operations
patients underwent (in other centers): endoscopic stenting (55.6%)
or percutaneous transhepatic drainage (44.4%). In all of the cases
we performed intrahepatic hepatico-jejunostomy in segment III
(58.3%) or segment V (41.7%) on Roux-en-Y loop. RESULTS:
Postoperative complications were observed in 18% of cases (bile
leakage 9%, right pleural exudate 5.3%, infection 3.7%). Two
patients (5.6%) died due to postoperative liver failure. We achieved
significant reduction at 60% of initial bilirubin serum concentration
and pruritus decreasing in 94% and 89% patients, respectively. Mean
length of hospitalization was 15 days. Mean survival was 7 months.
CONCLUSION: Intrahepatic, palliative segment III/V hepatico-
jejunostomy in patients with unresectable Klatskin tumors is an
effective, safe treatment modality, providing good palliation and
relieving the symptoms deteriorating the quality of life.
15 PAPILLARY ADENOCARCINOMA OF GALLBLADDER
WITH DISTAL BILE DUCT IMPLANTATION
Iype S, Kuruvilla AP, Surgical Gastroenterology, Medical College
Hospital, Trivandrum, Kerala, India
INTRODUCTION AND AIM: Papillary adenocarcinoma in
gallbladder has very poor prognosis. Intraductal spread and
implantation in distal common bile duct producing obstructive
jaundice is generally considered as inoperable.
CASE REPORT 1: A 43-year-old lady presented with recurrent
upper abdominal pain of 1 year duration. There was no history of
jaundice or loss of weight. On clinical examination, there was no
jaundice and abdominal examination did not show any mass or
hepatomegaly. On evaluation, ultrasonography showed a polypoidal
mass within the gallbladder and common bile duct (CBD) showed
dilatation of 1 cm, but there was no intrahepatic biliary radicle
dilatation. CT scan and MRCP confirmed the diagnosis. At laparo-
tomy findings were a fleshy polyp in the fundus of gallbladder 3r2
cm with no serosal infiltration, common bile duct was dilated to 1 cm,
no definite mass in CBD. CBD exploration was done, no. 3 dilator
passed with difficulty. A small bit of polypoidal tissue was removed
from CBD for biopsy. Radical cholecystectomy and T-tube drainage
of CBD was done. Pathology report came as carcinoma of gall-
bladder and polypoidal tissue from CBD shows similar histology.
Pylorus-preserving pancreaticoduodenectomy was done on sixth
postoperative day. On follow-up at 2 months, patient is asympto-
matic and healthy. CASE REPORT 2: A 44-year-old lady presented
with recurrent attacks of right upper quadrant pain of 1 year duration.
On clinical examination, there was no jaundice and abdominal
examination showed a hard gallbladder and hepatomegaly. On
evaluation, ultrasonography showed a mass within the gallbladder
and common bile duct showed dilatation with mass in the distal
CBD. Radical cholecystectomy with pancreaticoduodenectomy was
done. Patient had a disease-free survival for 1 year. CONCLUSION:
Carcinoma of gallbladder with intraductal spread is still amenable to
surgical resection. Although the overall survival rate is poor, it defi-
nitely improves the quality of life.
16 ROLE OF HEAVY METALS IN
PANCREATO-BILIARY MALIGNANCY
Sen G, Mansfield SD, Gallagher PV, Green P, Rimmer D,
Manas DM, Charnley RM, (1) Hepato-Pancreato-Biliary Surgery
Unit, Freeman Hospital, Newcastle; (2) Department of Agriculture,
University of Newcastle, Newcastle, UK
INTRODUCTION AND AIM: Heavy metals have been implicated
in human carcinogenesis. The aim of this study is to determine
a correlation between biliary heavy metals and pancreato-biliary
malignancy. PATIENTS AND METHODS: Bile was collected
from patients admitted with malignant biliary obstruction during
endoscopic retrograde cholangiography, percutaneous transhepatic
cholangiography or during surgery. Bile was collected from patients
with benign biliary disease as controls. The samples were analyzed
for concentrations of different heavy metals using atomic absorp-
tion spectrometry. The mean level of each metal in the study
groups (biliary malignancy and pancreatic malignancy) and the
control group were compared using standard statistical methods.
RESULTS: 101 bile samples were analyzed (30 cholangiocarcinoma,
43 pancreatic carcinoma and 28 benign). When the samples
from patients with cholangiocarcinoma were compared with the
benign group, the mean concentration of each metal was higher in
the malignant group except zinc but did not reach significant
level. Similarly, metal concentrations in patients with pancreatic
carcinoma were not significantly different from the benign group.
The mean level of cadmium reached closest to statistical signifi-
cance in each subgroup of biliary cancer compared to the benign
group. When all the samples from malignant disease were taken
together and compared with the benign group, the mean concen-
tration of cadmium was significantly higher in the former (p=0.02).
CONCLUSION: This study supports the possibility that higher
levels of heavy metals in bile may be associated with pancreato-biliary
malignancy. However, enough evidence is not available to implicate
heavy metals as a direct cause of these tumours.
17 HEPATOBILIARY CYSTADENOCARCINOMA:
A CASE REPORT
Karamarkovic AR, University Center for Emergency Surgery,
Surgical Dpt 3, Belgrade, Serbia and Montenegro
INTRODUCTION AND AIM: Hepatobiliary cystadenoma is a
rare neoplasm occurring in middle-aged women. The clinical feature
is not marked but abdominal fullness and abdominal mass are
the most common symptoms. PATIENTS AND METHODS: A
49-year-old woman was admitted to our clinic with right upper
quadrant abdominal discomfort and 6-cm-sized unilocular hepatic
cystic mass. The medical history was not unusual; laboratory tests
were normal. Serum CEA, CA 19-9, and alpha-fetoprotein levels
were normal. CT demonstrated a unilocular cyst in Couinaud’s
segment S4. The mass was localized on the under surface of the liver
between the round ligament and gallbladder, above the the hilar
structures, without communication with biliary tract. Anatomical
segmentectomy S4 was performed with curative intention (R0
resection). A unilocular cyst surrounded by a thin fibrous wall was
filled with mucinous and gelatinous fluid. Histologically, the inner
surface was lined with mucin-producing cuboidal epithelia accom-
panied by focal papillary growth, which is consistent with cysta-
denoma. The stromal mass was in situ papillary adenocarcinoma.
The postoperative course was uneventful. The patient is doing
well 14 months after surgery, without signs of tumor recurrence.
CONCLUSION: Cystadenocarcinomas usually arise from pre-
existing cystadenomas. The treatment of choice is complete surgical
resection.
18 IS MIRIZZI SYNDROME ASSOCIATED
WITH GALLBLADDER CANCER?
Ramia JM, Muffak K, Villar J, Garrote D, Ferro´n JA,
General Surgery, UH Virgen de las Nieves, Granada, Spain
INTRODUCTION AND AIM: Mirizzi syndrome (MS) is an
uncommon clinical situation. The incidence of gallbladder cancer
(GBC) associated with MS appears to be much higher than GBC
associated with cholelithiasis. We present two patients with MS type
II and GBC. PATIENTS AND METHODS: Case 1: A 74-year-old
woman presented abdominal pain and jaundice. Analytical results
showed cholestasis. Ultrasonography/CT: gallbladder not visible
and extrahepatic bile duct highly dilated and contained an 18-mm
stone. We performed cholecystectomy, primary fistula closure,
choledocotomy, stone extraction and placement of a Kehr’s tube.
Histological study reported a moderately differentiated adenocarci-
noma (T3NxMx). The patient refused a relaparotomy for radical
surgery and died 12 months after surgery due to disease progression.
Case 2: A 72-year-old man presented with abdominal pain and
jaundice. Analytical results showed a marked cholestasis. Ultra-
sonography/CT showed a 3-cm liver mass compatible with a gall-
bladder neoplasm. Intraoperative biopsy (gallbladder and periportal
lymph node) was reported as adenocarcinoma. The patient under-
went cholecystectomy, resection of the extrahepatic bile duct, portal
lymphadenectomy and segment IVb-V resection. Histologic study
reported a poorly differentiated adenocarcinoma (T4N1M0) Ten
months after surgery, the patient is alive, with no recurrence of
the tumor observed at follow-up. CONCLUSION: We highlight
that all patients with GBC and MS (our cases and literature search),
presented type II MS. We fully support the recommendation
to perform an intraoperative gallbladder biopsy in all patients with
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MS, especially in those with type II and elevation of CA19-9. If the
presence of a GBC is detected, radical surgery can be performed in
the same surgical act.
19 SMALL CELL NEUROENDOCRINE TUMOR OF THE
BILE DUCT
Ramia JM3, SanJuan F1, Lopez R1, Orbis JF1, Moya A1, De Juan M1,
Mir J1, Froufe A2, (1) General Surgery, Hospital La Fe de Valencia,
Valencia; (2) Pathology, Hospital La Fe de Valencia, Spain; (3)
University Hospital Virgen de las Nieves, General Surgery, Granada,
Spain
INTRODUCTION AND AIM: Neuroendocrine tumors of the bile
duct (NETBD) are an exceedingly rare neoplasm. The origin of
NETBD remains unclear. We present a patient with small cell
neuroendocrine tumor of the bile duct and discuss etiology and
treatment. PATIENTS AND METHODS: A 57-year-old man was
referred with a 5-day history of jaundice, acholia and choluria,
without abdominal pain. No neuroendocrine symptom was present.
Liver analysis was: bilirubin: 5.9 mg/dl AST: 208 UI/l, ALT: 354 UI/
l, LDH: 249 UI/l. CA19-9: 58.1 UI. CT, US and MR cholangio-
graphy showed a stenosis in the middle third of the bile duct with an
extrahepatic and intrahepatic bile duct dilatation. We performed a
resection of the extrahepatic bile duct, periportal lymphadenectomy,
and cholecystectomy. Pathologic examination revealed a small cell
undifferentiated neuroendocrine tumor of 3 cm diameter with
vascular thrombi, microscopic nerve and vascular invasion. No lymph
nodes were involved. Tumoral areas were positive for Grimelius.
Immunohistochemistry study: tumor stained positive for enolase,
synaptophysin, S-100, cromogranin, and was doubtful for AE1 and
AE3, and negative for CAM5.2, ALC, CD20, CD3, CD30. The
postoperative course was uneventful. After 4 months, the patient died
from tumoral recurrence confirmed by FNAC. CONCLUSION:
NETBD account for 0.2–2% of all neoplasms of the extrahepatic
biliary system. The clinical presentation does not differ from
cholangiocarcinoma. MR cholangiography is a very useful diagnostic
method. The preferred therapeutic approach to NETBD is resection.
Early metastases to regional lymph nodes appear to be common, and
rapid disease progression and death is the rule.
20 BILE DUCT OBSTRUCTION CAUSED BY A BILIARY
MUCIN-PRODUCING PAPILLARY NEOPLASM
Mu¨llner K1, Gyo¨keres T1, Schafer E1, Kovacs F1, Rusznyak K1,
Burai M1, Varga G3, Keleti G2, Pap A1, (1) Department of
Gastroenterology, MAV Hospital, Budapest; (2) Department of
Surgery, Szt Laszlo Hospital, Budapest; (3) Department of Surgery,
MAV Hospital, Budapest, Hungary
INTRODUCTION AND AIM: Biliary mucin-producing papillary
neoplasms are rare causes of biliary obstruction and recurrent
pancreatitis. The histological appearance and the clinical behaviour
of these biliary tumors largely resemble the properties of the
pancreatic mucin-producing neoplasms. RESULTS: A 48-year-old
woman was repeatedly hospitalised due to acute pancreatitis and
obstructive jaundice. ERCP erroneously localised the obstruction at
the level of the papilla, incomplete endoscopic sphincterotomy was
performed. She arrived at our institution because of recurrent jaun-
dice, 2 weeks after papillotomy. Sonography showed dilated intra-
hepatic and extrahepatic bile ducts. ERCP revealed mucinous bile
coming through the patulous papilla while causing obstruction. At
the hepatic bifurcation, a mild stenosis appeared with secretion of
descending mucin bubbles. Repapillotomy, nasobiliary and endo-
biliary drain implantation was performed. Per oral cholangioscopy
also verified the location of the mucin-producing adenoma at the
bifurcation of the hepatic ducts. The histological and cytological
examination of the samples taken from the ductus hepaticus showed
papillary mucin-producing adenoma. CONCLUSION: While 40–
70% of similar pancreatic lesions tend to transform into malignant
tumors, no data exist about the frequency of malignant transforma-
tion in the case of biliary mucin-producing adenomas. However, the
risk for secondary biliary cirrhosis and the possibility of malignant
transformation justify early surgical approaches. In our case resection
and hepato-jejunostomy was performed, confirming the mucin-
producing adenoma at the hepatic bifurcation.
21 TREATMENT OF THE COMPLICATION CAUSED BY
THE RECIDIVISTIC HILAR CHOLANGIOCARCINOMA
Lukovich P, Kupcsulik P, Zsirka A, 1st Surgical Department,
Semmelweis University, Budapest, Hungary
INTRODUCTION AND AIM: The hilar cholangiocarcinoma
grows slowly and very rarely produces metastases. In spite of the
small size of the tumour, oncologically radical resection is only
feasible – owing to the anatomical position – in approximately
35–50% of the cases. This makes recidivity frequent. The recidivistic
cancer involves the hilus of the liver, compresses the surrounding
organs and develops different complications. PATIENTS AND
METHODS: 51 patients underwent surgical resection in the 1st
Surgical Department of Semmelweis University from 1 January 1990
to 31 December 2003. Complete tumour-free surgical margins were
found in only 41% of the cases. The mean follow-up was 28.2 (4–54)
months. RESULTS: 14 patients were treated for complications
caused by local recurrence. These were mechanical jaundice
(12 cases), bleeding oesophageal varices (3 cases), gastric outlet
obstruction (2 cases), liver abscess (3 cases), pain caused by the
infiltration of the coeliac ganglion (3 cases) and a case of obstruction
of the ureter by a retroperitoneal metastasis. Most of the compli-
cations could be solved by minimally invasive therapy (percutaneous
transhepatic endoprothesis or drainage, endoscopic sclerotherapy,
ultrasound-guided drainage, percutaneous blockade of the coeliac
ganglion). Twice we carried out palliative re-resection of the tumor.
CONCLUSION: The fact that resected patients may survive several
years as long as patients treated with endoprothesis and irradiation
only survive half a year, has brought a change in the way Klatskin
cancer surgery is considered: resection of the tumour should be
striven for – even by way of R1 resection. Therefore the risk of
recurrence will increase.
22 FIRST ADULT CASE OF COMMON BILE DUCT
RHABDOMYOSARCOMA EMBRYONAL TYPE IN KOREA
Kim KH1, Kim JS1, Lim KW1, Park IY2, Lee KH3, (1) Department
of Surgery, Uijeongbu St Mary Hospital, Catholic University
of Korea, Uijeongbu; (2) Department of Surgery, Bucheon,
Family of Holy Hospital, Catholic University of Korea, Bucheon;
(3) Bupyeng, Our Lady of Mercy Hospital, Catholic University of
Korea, Bupyeng, Republic of Korea
We present a rare case of an embryonal-type rhabdomyosarcoma
at common bile duct. This is the first adult case reported in Korea.
A 59-year-old man was admitted to our hospital because of inter-
mittent abdominal pain in right upper quadrant and presented
with a short history of fever, jaundice and abdominal distension.
Computed tomography showed multiple CBD stones. At laparo-
tomy, a rhabdomyosarcoma (RMS) arising from the common bile
duct (CBD) was found. The tumor including the CBD was success-
fully excised and a Roux-en-Y hepaticojejunostomy was performed.
Postoperatively, the patient received chemotherapy and is doing
well at 1-month follow-up.
23 DETECTION OF BILIARY TRACT MALIGNANCY
USING SELDI-TOF MASS SPECTROMETRY ANALYSIS
OF BILE
Tuynman JB6, Groen AK1, van Delden OM2, Richel DJ3, Aerts JM4,
Gouma DJ5, (1) Liver Center AMC; (2) Radiology; (3) Medical
Oncology; (4) Biochemistry; (5) Surgery; (6) Academic Medical
Center, Experimental Surgery, Amsterdam, The Netherlands
INTRODUCTION AND AIM: Differentiation of benign and
malignant biliary strictures is difficult despite modern MR cholan-
giography and cytological analysis of bile. Because of these limita-
tions, the incidence of finding benign, inflammatory lesions in
patients resected for presumed hilar carcinoma is 15%. A more
reliable preoperative diagnosis is highly desirable in view of the
extent of surgical intervention. Advances in proteomics like surface-
enhanced laser desorption/ionization-time of flight (SELDI-TOF)
mass spectrometry potentially provides a powerful diagnostic tool
for biliary strictures. We hypothesize that employing the SELDI-
TOF technique to bile enables us to differentiate between benign
or malignant biliary strictures. PATIENTS AND METHODS:
Bile was collected from 20 patients with a biliary tract malignancy
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or benign biliary stricture from percutaneus biliary drainage tubes.
The protein mass spectrometric profiles of the bile samples were
obtained by SELDI-TOF technique and 2D gel electrophoresis.
Diagnosis was confirmed histologically after resection or surgical
biopsy. RESULTS: After optimizing the technique for bile, we
obtained reliable mass spectrometric profiles in bile. Remarkably,
malignancy was distinguished from benign disease including
primary sclerosing cholangitis by the presence of prominent and
specific peaks between 7.5 and 13.5 kDa in 90% of the malignant
cases. These findings were validated by 2D gel electrophoresis.
CONCLUSION: We conclude that SELDI-TOF analysis has the
capacity to detect malignancy in bile. This novel technique can
provide biomarkers of malignancy to improve diagnosis and
management of patients presenting with a biliary stricture.
24 HIGH EXPRESSION OF CLAUDIN-4 IN
HUMAN CHOLANGIOCARCINOMAS
Lodi C2, Szijarto A1, Holczbauer A2, Szabo E2, Batmunkh E2,
Kiss A2, Illyes G2, Schaff Z2, Kupcsulik P1, (1) 1st Department
of Surgery; (2) 2nd Department of Pathology,
Semmelweis University, Semmelweis, Budapest, Hungary
INTRODUCTION AND AIM: Cell adhesion molecules play an
important role in carcinogenesis, especially claudins, being part of
tight junctions. The importance of certain claudins in development
of several tumors has been shown, and some of them have even been
suggested as a future therapeutic target. For this reason, the aim
of our study was to analyse the expression of claudins in cholangio-
carcinomas (CCs). PATIENTS AND METHODS: A tissue
microarray comprising 24 bile duct tumors, arising from different
localisations (gallbladder, common bile duct, intrahepatic bile ducts)
was constructed to investigate claudin-1, -2, -3, -4, -7 expression
by immunohistochemistry. Claudin-4 was further investigated by
Western blot analysis on 5 human surgically resected, snap-frozen
CC specimens. Subcellular localisation of claudin-4 was detected by
confocal laser scanning microscopy. RESULTS: Intensive mem-
branous immunolabeling was found for claudin-4 in BDTs of
different origin. A single band of the expected size was detected on
Western immunoblots and revealed a strong expression of claudin-4.
Confocal microscopy confirmed the increased expression of claudin-
4 on the membrane of CC cells. CONCLUSION: Our data are
the first to report a significantly increased claudin-4 expression
in CCs. The results represent a novel feature of CCs and claudin-4
protein could well become a potential diagnostic marker and ther-
apeutic target for cholangiocarcinomas, as it has been suggested
for pancreatic and ovarian cancers. The project was supported
by grants: Bio14/2001, NKFP-1/0023/2002, ETT-228/2001,
OTKA-T037838.
25 FACTORS INFLUENCING OUTCOME AFTER
SURGICAL RESECTION IN PATIENTS WITH KLATSKIN
TUMORS
Figueras J1, Llado L1, Ramos E1, Torras J1, Valls C2, Serrano T3,
Lamas S1, Montserrat A1, Rafecas A1, (1) Department of Surgery;
(2) Department of Radiology; (3) Department of Pathology,
Hospital Universitario de Bellvitge, Barcelona, Spain
INTRODUCTION AND AIM: Complete surgical resection is the
only potentially curative treatment for hilar cholangiocarcinoma.
More radical approaches have been proposed, including systematic
liver resection and portal vein resection when needed. The aim of
this study was to evaluate the long-term survival in patients resected
for Klatskin tumor, and determine the main prognostic factors.
PATIENTS AND METHODS: From 1989 to 2004, 47 patients
with Klatskin tumors have been operated with curative intention.
There were 37 men and 10 women, with a mean age of 60+11 years.
Preoperative biliary drainage was used in 14 cases (30%). Hepa-
tectomy was performed in 41 patients (87%), portal vein resection
was associated in 11 patients (23%), and duodenopancreatectomy
in 1 patient. RESULTS: Nine patients died during hospitalization
after resection. There was postoperative morbidity in 37 patients
and mean hospital stay was 22+18 days (range: 4–108). Margins of
bile duct resection were free from tumor on histologic examination
in 37 cases (79%). Mean patient survival, excluding postoperative
mortality, was 32+22 months (range 4–106). The cumulative
survival rate was 74% at 1 year, 53% at 3 years, and 39% at 5 years.
Univariate analysis indicated only the histopathologic grade as a
significant prognostic factor for survival. CONCLUSION: The
use of radical approaches to treat patients with Klatskin tumors is
associated with high postoperative morbidity and mortality rates,
but offers long-term survival.
26 INTRAHEPATIC SEGMENTAL BILE DUCT B3
CHOLANGIOENTERIC BYPASS IN THE MANAGEMENT
OF UNRESECTABLE MALIGNANT HILAR OBSTRUCTION
Karamarkovic AR, Radenkovic D, 3rd Surgical Department,
University Center for Emergency Surgery, Belgrade, Serbia
and Montenegro
INTRODUCTION AND AIM: Palliating the effects of biliary
obstruction is a major goal of therapy in patients with unresectable
cancer at the hepatic duct confluence. This study was undertaken to
evaluate the effectiveness of intrahepatic cholangioenteric bypass
to the segmental bile duct B3 in patients with unresectable hilar
cholangiocarcinoma or gallbladder carcinoma. PATIENTS AND
METHODS: The confluence pattern and surgical anatomy of the
bile duct branch B3 of segment S3 of the liver was studied in 33
liver casts. It is important to understand the detailed anatomy of B3,
its confluence patterns and its relation to the segmental portal venous
branch P3. We did not register any anatomical variations of
segmental biliary ducts B2 and B3. RESULTS: Since March 2001,
we have performed intrahepatic segmental bile duct B3 cholangio-
jejunostomy by Roux-en-Y fashion utilizing a round ligament
approach in 13 patients with malignant obstructive jaundice due
to unresectable hilar cholangiocarcinoma (8 cases) and gallbladder
cancer (5 cases). There were no postoperative surgical complications
(postoperative bleeding, bile leakage, abscess formation) in our
series. Operative mortality rate after B3 cholangiojejunostomy
was 7.7% (one patient). The palliation of symptoms was effective
in the postoperative period. Median survival after cholangioenteric
bypass was 9 months (range 1–22 months). CONCLUSION:
Intrahepatic B3 cholangiojejunostomy can provide useful palliation
from jaundice, pruritus and cholangitis with acceptable mortality
and morbidity rates. Among the surgical and non-surgical palliative
treatments of malignancies of the hilus, the intrahepatic cholangio-
anastomosis is the procedure which gives the best comfort and
less iatrogenic complications.
27 HILAR CHOLANGIOCARCINOMA – ANALYSIS
OF DIAGNOSTIC WORK-UP, SURGICAL APPROACH AND
RESULTS IN 111 PATIENTS
Otto GM1, Otto G1, Thies J1, Romaneehsen B2, Bittinger F3, (1)
Transplantation and Hepatobiliary Surgery; (2) Radiology; (3)
Pathology, University of Mainz, Mainz, Germany
INTRODUCTION AND AIM: To achieve high resection rates
and high rates of curative resection is a prinicipal goal in patients
with hilar cholangiocarcioma (hilCC). Diagnostic work-up and
surgical strategy have been shown to influence results. PATIENTS
AND METHODS: Between 9/1997 and 9/2004, 111 patients with
hilar cholangiocarcinoma were treated at our institution. The results
of routine diagnostic work-up (ERC, PTC, CT and MRI) were
compared with the surgical specimen, and their influence on surgical
strategy as well as on survival was assessed. RESULTS: Resection
was performed in 78 patients (9 hilar tumor resections, 69 en-bloc
resections of tumor and liver; resection rate 71%). Hospital mortality
was 5.1%. Curative resection was achieved in 73% of the resected
patients. Right, extended right and left hepatectomy were performed
in 22, 12 and 35 patients, respectively. The resection to be performed
was predicted in 80% of the patients, the extent of the tumor was
best predicted by PTC. Overestimation of the extent of the tumor
occurred more frequently (30%) than underestimation (10%).
5-year survival in resected patients was 30% (median survival 813
days) compared to 0% (median survival 117 days) in non-resected
patients. After curative resection 5-year survival was 48%, in patients
with R0/N0 situation it was 61%. CONCLUSION: The accuracy
of routine diagnostic work-up in patients with hilCC allows for
preoperative decisions in the majority of patients. The resection
rate and the rate of curative resection may exceed 70%. The tumor
is frequently overestimated, which must not lead to exclusion of
these patients from surgery.
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28 CHRONOLOGICAL CHANGES OF SURGICAL
OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS
IN GB CANCER
Kim SW, Choi M, Han SS, Jang JY, Park YH, Department
of Surgery, Seoul National University College of Medicine,
Seoul, South Korea
INTRODUCTION AND AIM: To analyze chronological changes
of surgical management and outcomes of GB cancer patients and
to identify the prognostic factors. PATIENTS AND METHODS:
The subjects were 192 GB cancer patients between 1996 and 2002.
Clinicopathologic features and significant prognostic factors were
analyzed and the results were compared with those of previous period
(1987*1995). RESULTS: There were 99 men and 93 women, with
a mean age of 62.0 years. Curative resections were performed in 106
(55.2%). In the curative resection group, multivariate analysis
demonstrated that T stage and histological grade were independent
variables. The 5-year survival rate was 41.4% and in the curative
resection group, the rates according to AJCC stage I, II, and III
were 87.3%, 48.2%, and 0.0%. When compared with a previous
study, 5-year survival rate has increased from 21.1% to 41.4% and,
in the curative resection group, from 42.9% to 72.1%. Though
curative resection rates were similar between the two periods
(50.4% vs 55.2%), the proportion of incidentally detected patients
has increased from 8.8% to 20.3% and stage I*II increased from
24.8 to 37.5%. Compared to the previous period, more extended
resections were performed in the same T stage and improved survival
rates in the same stage were observed in the recent period.
CONCLUSION: The significant prognostic factors were T stage
and histological grade in the present study. Improved surgical
outcome compared to the previous period may be due to early
detection and more aggressive surgical approach.
29 IMPROVED OPERATIVE AND SURVIVAL
OUTCOMES OF SURGICAL TREATMENT FOR HILAR
CHOLANGIOCARCINOMA
Liu CL1, Fan ST1, Lo CM1, Tso WK2, Wong J1, (1) Department
of Surgery, University of Hong Kong, Queen Mary Hospital,
Hong Kong; (2) Department of Radiology, Queen Mary Hospital,
Hong Kong, China
INTRODUCTION AND AIM: The aim of the present study was
to assess whether improved operative and survival outcomes were
associated with an aggressive surgical approach in the management
of hilar cholangiocarcinoma. PATIENTS AND METHODS: We
evaluated 141 consecutive patients with hilar cholangiocarcinoma
treated between 1989 and 1999 (Period 1, n=84), and between 2000
and 2004 (Period 2, n=57). During Period 1, relief of biliary
obstruction was primarily made by endoscopic stenting. In Period 2,
modifications of management of the patients included percutaneous
biliary drainage for relief of biliary obstruction, preoperative portal
vein embolization before right-sided hepatectomy, routine total
caudate lobectomy and radical lymphadenectomy during surgical
resection of the tumor. RESULTS: Sixteen patients (19%) in Period
1 and 23 patients (40%) in Period 2 underwent surgical resection of
the tumor (p=0.006). All except one patient in Period 1 underwent
major hepatectomy. Three patients (19%) in Period 1 and all patients
in Period 2 underwent concomitant caudate lobectomy (p50.001).
The operative morbidity rate decreased significantly from 81% to
48% (p=0.049), and hospital mortality rate from 44% to 4%
(p=0.004) in Period 2. The median survival of the patients after
resection in Period 1 was 4.7 months and that of the patients in
Period 2 was 25 months (p50.001). In Period 2, 14 patients (61%)
remained disease-free with a median follow-up of 20 months (range
5–40 months). CONCLUSION: An aggressive surgical approach
in the management of patients with hilar cholangiocarcinoma was
associated with improved operative and survival outcomes.
30 HILAR CHOLANGIOCARCINOMA: LIVER
TRANSPLANTATION AND PARTIAL
PANCREATODUODENECTOMY (VIDEO)
Jonas S, Thelen A, Neuhaus P, General, Visceral & Transplantation
Surgery, Charite´ Campus Virchow-Klinikum, Berlin, Germany
INTRODUCTION AND AIM: In the surgical therapy of hilar
cholangiocarcinoma, no-touch techniques and wide margins can
only insufficiently be complied with. In 1992, liver transplantation
and partial pancreatoduodenectomy (LTX/Whipple) as a combined
en bloc resection was introduced into our therapeutic algorithm as
a strategy to eradicate the entire biliary tract without touching
the tumor. Due to the favorable results which can meanwhile be
obtained with right trisectionectomy and portal vein resection, only
non-resectable hilar cholangiocarcinomas are evaluated for LTX/
Whipple. Local irresectability may be due to an associated PSC with
bilateral disease or a bilateral duct infiltration beyond the umbilical
fissure on the left. The umbilical fissure is the utmost topographical
landmark indicating resectability by right trisectionectomy unless
infiltrated. PATIENTS AND METHODS: From 1992 to 2004,
16 patients underwent LTX/Whipple. Most hilar cholangiocar-
cinomas (n=9) were eventually node-positive. RESULTS: The
postoperative 60-day mortality rate was 12.5%; the rate of curative
resections was 94%. 1- and 5-year-survival rates after curative
resections were 71% and 39%, respectively. Recurrent tumors
arose mainly as implantation metastases. Recurrent malignancy
was observed in 8 of 16 patients including 4 patients suffering from
peritoneal carcinomatosis. The other 4 patients suffered from tumors
at the jejunojejunal anastomosis, at the terminal ileum or within
the abdominal wall (n=2). CONCLUSION: Though the rate of
curative resections increased by LTX/Whipple, we have modified
this procedure. Today a double-stapling technique of the gastric
stump and the upper jejunum is used in order to minimize the risk
of implantation metastases, which increases under immuno-
suppression. This modification is in analogy to the double-stapling
technique used in total mesorectal excision for rectal cancer.
31 THE USE OF LAPAROSCOPY AND INTRA-
OPERATIVE ULTRASOUND FOR ASSESSMENT OF THE
RESECTABILITY OF CHOLANGIOCARCINOMA
Pattenden CJ, Barlow A, Garcea G, Sutton C, Neal C, Dennison A,
Berry D, Hepatobiliary Surgery, Leicester General Surgery,
Leicester, UK
INTRODUCTION AND AIM: The majority of patients with
cholangiocarcinoma have inoperable and therefore incurable
disease at presentation due to the extent of the disease. The aim of
this study was to evaluate the role of laparoscopy with or without
intra-operative ultrasound in patients with potentially resectable
disease on cross-sectional imaging. PATIENTS AND METHODS:
Our multidisciplinary team database was searched for patients
diagnosed with cholangiocarcinoma between 1999 and 2004. Patient
data included demographic details, procedures and outcome and
were collected on a computerized database. RESULTS: 116 patients
(55 males, 61 females) with a diagnosis of cholangiocarcinoma were
identified between 1999 and 2004. Of these 67 (58%) had potentially
resectable disease on pre-operative radiological imaging. Laparo-
scopy was performed in 54 (81%) of these patients prior to resection,
with 34 of these undergoing simultaneous intra-operative ultra-
sound. 22 (41%) patients were deemed inoperable at laparoscopy
(9 due to extrahepatic disease, 11 due to extensive intrahepatic
disease and 2 due to both). 30 patients who had had laparoscopy
went on to have open surgery, of these 6 (20%) were found to be
inoperable at that time. Two patients were medically unfit for
laparotomy. Thirteen patients proceeded directly to open surgery,
without staging laparoscopy: 5 (38%) were then found to be in-
operable. CONCLUSION: Over 40% of patients with potentially
resectable cholangiocarcinoma on their pre-operative radiological
imaging are understaged and deemed inoperable at staging laparo-
scopy. Laparoscopy is an essential pre-operative staging investigation
for cholangiocarcinoma.
32 PHOTODYNAMIC THERAPY (PDT) IMPROVES
SURVIVAL IN NON-RESECTABLE HILAR
CHOLANGIOCARCINOMA – ENCOURAGING
PRELIMINARY RESULTS
Tait S2, Ziyaie D1, Polignano F1, Hamdan K2, (1) Surgery,
Ninewells Hospital & Medical School, Dundee; (2) Surgery &
Molecular Oncology, Ninewells Hospital & Medical School,
Dundee, UK
INTRODUCTION AND AIM: Most patients (80%) with hilar
cholangiocarcinoma require palliation with biliary stent(s) and have
median survival of 3–4 months, even with chemo/radiotherapy.
This study evaluates efficacy of Photofrin-PDT for advanced
(non-resectable) hilar cholangiocarcinoma. PATIENTS AND
METHODS: From January 2002 to November 2004, 17 patients
with advanced cholangiocarcinoma were offered PDT and 12
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proceeded; 5 refused and received systemic gemcitabine. Stents
were placed at ERCP and brushings obtained for cytology. Patients
were given photosensitiser Photofrin 2 mg/kg, then PDT 48 h later
via ERCP (n=11) or PTC (n=1). Drug was activated by 630-nm
laser using optical fibre to deliver a light dose of 180 J/cm2.
Patients were re-stented after PDT, antibiotics, monthly follow-up.
RESULTS: There were 9 males and 3 females, median age 70 (range
59–78). Bismuth type II-1, IIIa-4, IIIb-3, IV-4. PDT was given
2.3 months from diagnosis (range 1–5, median 2). Mean hospital
stay was 12 days (range 3–48, median 8). Average survival was
683 days [CI 446,920] and median survival was 546 days [CI
427,665] after PDT, compared with mean and median survival of
161 [67,225] days and 200 days with chemotherapy (Kaplan-Meier
log rank, p=0.0046). Overall survival with PDT was 100% at
6 months, 75% at 1 year, and 50% at 18 months. Early side effects:
abdominal pain 1, cholangitis 1, haematemesis 1, mild skin photo-
toxicity 3. Number of re-admissions was 2.4 (range 1–5, median 2),
re-interventions 3 (range 0–4, median 3). There was no in-hospital
or 30-day mortality. CONCLUSION: This study demonstrates
PDT to be an effective treatment for non-resectable hilar cholan-
giocarcinoma that is associated with substantial prolonged survival.
This observation merits further validation in a larger multi-centre
randomised controlled trial.
33 HILAR CHOLANGIOCARCINOMA – A SINGLE
CENTER EXPERIENCE
Iype S, Subhalal N, Kuruvilla AP , Surgical Gastroenterology,
Medical College Hospital, Trivandrum, Kerala, India
INTRODUCTION AND AIM: Hilar resection, especially in
combination with liver resection, results in substantial morbidity
and mortality, which clearly influences the overall outcome. In
the present study resectability rate, operative mortality, long-term
survival, and factors contributory to long-term survival were inves-
tigated. PATIENTS AND METHODS: Between January 1991 and
June 2004, 81 consecutive patients with hilar cholangiocarcinoma
were studied retrospectively. Patients presented with obstructive
jaundice, pruritus and loss of weight. The main preoperative
evaluation tool was ultrasonography combined with Doppler exam-
ination. PTC, ERCP and MRCP were done in a few selected cases.
Patients undergoing hepatic resection with extrahepatic bile duct
resection, patients undergoing bile duct resection only and patients
undergoing palliative bypass were retrospectively compared for
operative morbidity, mortality and survival. RESULTS: Analysis of
the surgical management of 81 consecutive patients with carcinoma
at the confluence of the hepatic ducts showed that 23 (28%) were
resectable after comprehensive pre-operative investigation and
underwent tumour resection – 5 local resections and 19 liver resec-
tions. The 30-day hospital mortality was 21% and mean duration of
survival was 15 months (8 patients are still alive). The quality of life
was also much improved after resection. Curative resection was
possible in 72% of patients. In patients treated with palliative
surgery the hospital mortality was 16% and the mean survival was
7 months. CONCLUSION: It is clear that cancer of the main
hepatic duct junction has become a curable disease. Aggressive
surgical approaches to obtain curative resections could bring about
a better prognosis in hilar cholangiocarcinoma independently of
whether hepatic resection or local resection is performed.
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